DOW Dow Inc.
Deep-trough commodity chemicals priced for recovery; the stock is fairly valued only if mid-cycle spreads return before leverage forces dilution.
The story
Dow is a scale commodity chemicals producer (polyethylene, intermediates, silicones) with advantaged US Gulf Coast ethane feedstock but no pricing power. It is stuck in a deep, prolonged cyclical trough: Chinese capacity additions and weak European demand are compressing spreads, the reported margin is about 1% TTM and negative in the latest year, and the company is losing money while carrying $13B of net debt. It is a mature, cyclical business, so its value depends on margins recovering toward mid-cycle levels rather than on growth.
All drivers are unchanged from the 2026-10-13 take. TTM results (about 1% margin, -$0.9B net income) confirm the trough we already assumed, and they do not change the mid-cycle economics. The 8.5% target margin, reached over 5 years, reflects normalized ethane-advantaged spreads rather than the 2022 peak of 11.9%. The 1.1 sales-to-capital ratio is deliberately below the current 1.29 because new capacity like Path2Zero is capital-heavy. A 5% failure probability reflects leverage that only matters if the trough lasts several more years.
Value drivers
| Revenue growth (Y1) | 0.0% |
| Terminal growth | 2.0% |
| Forecast horizon | 6y |
| Target operating margin | 8.5% |
| Years to target margin | 5 |
| Sales-to-capital | 1.10 |
| Beta | 1.20 |
| Failure probability | 5.0% |
| Cost of capital (WACC) | 9.7% |
| Terminal WACC | 9.2% |
Valuation bridge
| PV of explicit FCFF | 7.06B |
| PV of terminal value | 19.43B |
| Equity value | 11.17B |
| ÷ shares → per share | $15.43 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 42.61B | 0.0% | 2.5% | 846.58M | 0 | 846.58M | 771.86M |
| 2 | 42.78B | 0.4% | 4.0% | 1.36B | 154.96M | 1.20B | 998.14M |
| 3 | 43.13B | 0.8% | 5.5% | 1.88B | 311.15M | 1.57B | 1.19B |
| 4 | 43.64B | 1.2% | 7.0% | 2.41B | 470.46M | 1.94B | 1.34B |
| 5 | 44.34B | 1.6% | 8.5% | 2.98B | 634.81M | 2.34B | 1.48B |
| 6 | 45.23B | 2.0% | 8.5% | 3.04B | 806.21M | 2.23B | 1.28B |
Key risks
- Chinese and Middle Eastern polyolefin capacity keeps global spreads depressed beyond 2028, keeping margins below 5%
- Leverage: $19.6B gross debt against negative earnings could force asset sales, further dividend cuts, or equity issuance at bad prices
- A narrowing gap between US ethane and global naphtha costs would erode Dow's core cost advantage
Catalysts
- Industry capacity rationalization in Europe and Asia, including Dow's own European closures, tightening supply
- Cost-cutting and deferred capex such as delaying Path2Zero, which would lift free cash flow and protect the balance sheet